Company profile
UK company 09029209, incorporated on 8 May 2014.
Therapeutic Frontiers Limited is a UK company with status active founded in 2014 based in London.
Company number 09029209
Reference milestones and recent Companies House filing stream events.
Company registered at Companies House
Founded from the National Heart and Lung Institute (NHLI) within Imperial College London (ICL), Therapeutic Frontiers have over 20 years' experience in the infection of human volunteers with rhinovirus (RV). Stemming from the early work of CEO Professor Sebastian L Johnston, the human infection model has been performed successfully in healthy volunteers, asthmatic (including moderate and severe) and COPD patients.
Uniquely, TF are the only such group worldwide to successfully infect and study severe asthmatic and COPD patients providing a new pipeline to proof of concept clinical trials in relevant patient groups. These progressive human infection models are further enhanced by the scientific experience provided by Dr Michael R Edwards and Dr Ross P Walton who have novel expertise in cellular, molecular and immunological assays, delivering academic excellence to meet and exceed today's industrial expectations.
